Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Carlson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Data|November 24, 2019
SeaFlow data v1, high-resolution abundance, size and biomass of small phytoplankton in the North PacificFrançois Ribalet, Chris Berthiaume, Annette Hynes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2003
Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotypeGabriella Segal-Lieberman, Richard L Bradley, Efi Kokkotou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 5, 2022
Artificial intelligence-augmented histopathologic review using image analysis to optimize DNA yield from formalin-fixed paraffin-embedded slidesBolesław L Osinski, Aïcha BenTaieb, Irvin Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2025
Response: Promise and open questions of optogenetic vision restoration by MCOSamarendra K Mohanty, Santosh Mahapatra, Subrata Batabyal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 23, 2025
A synthetic opsin restores vision in patients with severe retinal degenerationSamarendra K Mohanty, Santosh Mahapatra, Subrata Batabyal, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|March 14, 2026
Validation of a novel multi-luminance shape discrimination test for assessment of functional visionAndres Emanuelli, Benjamin Bakall, Byron L Lam, et al.
Eclinicalmedicine|August 21, 2025
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialByron L Lam, Vitaliy Zak, Victor H Gonzalez, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Data|November 24, 2019
SeaFlow data v1, high-resolution abundance, size and biomass of small phytoplankton in the North PacificFrançois Ribalet, Chris Berthiaume, Annette Hynes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2003
Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotypeGabriella Segal-Lieberman, Richard L Bradley, Efi Kokkotou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 5, 2022
Artificial intelligence-augmented histopathologic review using image analysis to optimize DNA yield from formalin-fixed paraffin-embedded slidesBolesław L Osinski, Aïcha BenTaieb, Irvin Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2025
Response: Promise and open questions of optogenetic vision restoration by MCOSamarendra K Mohanty, Santosh Mahapatra, Subrata Batabyal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 23, 2025
A synthetic opsin restores vision in patients with severe retinal degenerationSamarendra K Mohanty, Santosh Mahapatra, Subrata Batabyal, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|March 14, 2026
Validation of a novel multi-luminance shape discrimination test for assessment of functional visionAndres Emanuelli, Benjamin Bakall, Byron L Lam, et al.
Eclinicalmedicine|August 21, 2025
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialByron L Lam, Vitaliy Zak, Victor H Gonzalez, et al.
Pageof 3